Evidence map›Paper›PMID 37415957›Full record

ArticleMolecular genetics and metabolism reports2023

Growth patterns in patients with mucopolysaccharidosis VII.

Adriana M Montaño, Agnieszka Różdżyńska-Świątkowska, Agnieszka Jurecka, Antonio Nino Ramirez, Lin Zhang, Deborah Marsden, Raymond Y Wang, Paul Harmatz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular genetics and metabolism reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Adriana M MontañoDepartment of Pediatrics, and Biochemistry and Molecular Biology, School of Medicine, Saint Louis University, St. Louis, MO, USA.
Agnieszka Różdżyńska-ŚwiątkowskaAnthropology Laboratory, Children's Memorial Health Institute, Warsaw, Poland.
Agnieszka JureckaUltragenyx Pharmaceutical Inc., Novato, CA, USA.
Antonio Nino RamirezUltragenyx Pharmaceutical Inc., Novato, CA, USA.
Lin ZhangUltragenyx Pharmaceutical Inc., Novato, CA, USA.
Deborah MarsdenUltragenyx Pharmaceutical Inc., Novato, CA, USA.
Raymond Y WangDivision of Metabolic Disorders, Children's Hospital of Orange County, USA.
Paul HarmatzUCSF Benioff Children's Hospital, Oakland, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study assessed growth patterns in patients with mucopolysaccharidosis (MPS) VII before enzyme replacement therapy. Methods: Height, weight, and body mass index (BMI) measurements and Results: Among 20 enrolled patients with MPS VII, height Conclusions: In patients with MPS VII, declines in height

Indexed as

GrowthHeightMPS VIIWeight, BMI

Identifiers

PMID37415957
PMCPMC10320588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.